Endothelial function and coronary risk reduction: mechanisms and influences of nitric oxide

Cardio-Vascular Nursing
|May 1, 1996
PubMed

Insights

Understanding the complex mechanisms of coronary artery disease (CAD) progression and regression is crucial. Focusing on both vascular function and artery structure, alongside lipid lowering, enhances our understanding of risk reduction interventions for CAD.

Area of Science:

  • Cardiovascular Biology
  • Pathophysiology of Atherosclerosis

Background:

  • Coronary artery disease (CAD) progression and regression involve complex biological mechanisms.
  • Endothelial injury and lipid accumulation are key factors, but endothelial modulation of vasodilation (vascular function) is also critical.
  • Current research often emphasizes artery structure (plaque regression) over vascular function.

Purpose of the Study:

  • To highlight the underappreciated role of endothelial function in CAD progression, regression, and stabilization.
  • To advocate for a research approach that integrates both vascular function and artery structure.
  • To explore how risk reduction interventions impact CAD beyond lipid lowering.

Main Methods:

  • Review of existing literature on CAD mechanisms and risk reduction.
  • Analysis of the interplay between endothelial function, vascular tone, and atherosclerotic processes.
  • Synthesis of evidence on the effects of interventions on both structural and functional aspects of CAD.

Main Results:

  • Endothelial function significantly influences CAD progression, regression, and stabilization.
  • Risk reduction interventions may favorably impact vascular function, warranting further investigation.
  • A dual focus on function and structure provides a more comprehensive understanding of CAD.

Conclusions:

  • A holistic approach considering both vascular function and artery structure is necessary for a complete understanding of CAD.
  • Further research into the role of endothelial function and its modulation by interventions is essential for effective CAD management.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...